Group One Trading’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-200
| Closed | -$1K | – | 5804 |
|
|
2019
Q1 | $1K | Buy |
+200
| New | +$681 | ﹤0.01% | 4712 |
|
|
2018
Q4 | – | Sell |
-15,900
| Closed | -$55K | – | 5951 |
|
|
2018
Q3 | $55K | Sell |
15,900
-8,000
| -33% | -$30K | ﹤0.01% | 3929 |
|
|
2018
Q2 | $109K | Buy |
23,900
+22,700
| +1,892% | +$90.4K | ﹤0.01% | 3514 |
|
|
2018
Q1 | $4K | Hold |
1,200
| – | – | ﹤0.01% | 4578 |
|
|
2017
Q4 | $5K | Buy |
+1,200
| New | +$6.54K | ﹤0.01% | 4583 |
|
|
2017
Q2 | – | Sell |
-11,700
| Closed | -$80K | – | 5511 |
|
|
2017
Q1 | $80K | Buy |
11,700
+10,500
| +875% | +$60.7K | ﹤0.01% | 3117 |
|
|
2016
Q4 | $7K | Buy |
+1,200
| New | +$8.48K | ﹤0.01% | 4053 |
|
|
2016
Q1 | – | Sell |
-300
| Closed | -$6K | – | 5540 |
|
|
2015
Q4 | $6K | Sell |
300
-1,700
| -85% | -$29.3K | ﹤0.01% | 4356 |
|
|
2015
Q3 | $24K | Buy |
+2,000
| New | +$37.5K | ﹤0.01% | 3964 |
|
Group One Trading's IMDZ Position: Q2 2018 in Review
Group One Trading sold out of Immune Design Corp. (IMDZ) in Q2 2018, closing a stake of 17,594 shares — an estimated $70.1K sold.
Group One Trading first reported a position in IMDZ in Q3 2015 and held it in 7 quarters. The position peaked at $71K in Q4 2017. 80 funds tracked by Wall St. Rank hold IMDZ as of Q2 2018.
- Group One Trading reported no remaining Immune Design Corp. position as of Q2 2018 after selling out during the quarter.
- Group One Trading sold 17,594 Immune Design Corp. shares in Q2 2018, an estimated $70.1K.
- Group One Trading first reported a position in Immune Design Corp. in Q3 2015 and held it in 7 quarters.
- Group One Trading's Immune Design Corp. position peaked at $71K in Q4 2017.
- 80 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2018.
Based on Group One Trading's 13F filing for Q2 2018, filed 14 Aug 2018.